Former Ford Dealership Manager Pleads Guilty To Prescription Drug Distribution Charges
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Former Ford Dealership Manager Pleads Guilty To Prescription Drug Distribution Charges

Former Ford Dealership Manager Pleads Guilty To Prescription Drug Distribution Charges

February 03, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Rosa Valle-Lopez
Phone Number: (571) 387-5045

RENO, Nev. - Richard Winston West II, aka Richie West, former manager of the Jones-West Ford dealership in Reno, pleaded guilty today to prescription drug conspiracy and possession with intent to distribute oxycodone.  Special Agent in Charge Steve Comer of the DEA’s Los Angeles field division, U.S. Attorney Daniel G. Bogden of the District of Nevada, and Special Agent in Charge Aaron C. Rouse of the FBI’s Las Vegas field office jointly announced the plea.  At the time of sentencing, West faces up to 20 years in prison for his plea of guilty to the conspiracy charge. Sentencing is set for May 8, 2017.

“While the immediate impact on the Reno community is profound, sadly this case is representative of the broader national threat we face in prescription opioid misuse and addiction,” said Comer.  “Torn communities, broken homes and lost lives demonstrate vividly the fight we are engaged in, and DEA will continue to combat these horrors by identifying, investigating and arresting those responsible for the illicit distribution of controlled pharmaceutical drugs.”

“Prescription drug abuse is a major public health and public safety issue. Nevada citizens should be concerned and be aware of its dangerous impact and effects,” said Bogden.  “We are fighting collaboratively with our law enforcement partners pursuing dirty doctors and illicit pill mills to ensure that our communities remain safe and that we bring wrongdoers to justice and stem the rising tide of prescription drug abuse.” 

“The successful investigation of this case is through the extraordinary and dedicated work by the FBI and our federal, state, and local law enforcement partners,” said Rouse.  “This case shows the seriousness the FBI places on the upward trend of opioid addiction supported by the unscrupulous acts of the very people who should be looking out for their patients’ best interests.  This is not the end of this problem, but the community should know that the FBI will be steadfast in our resolve to stem the tide in Nevada,”

West, 40, was one of nine defendants charged on May 11, 2016, with conspiracy to distribute and possess with intent to distribute controlled substances, including oxycodone.  According to admissions made in the plea agreement, beginning in November 2012 and continuing to April 2016, West conspired with co-defendant Dr. Robert Gene Rand, a Nevada physician who operated Rand Family Care in Reno, and others to illegally distribute and possess with intent to distribute prescription controlled substances, including oxycodone.  At relevant times of the conspiracy, West obtained oxycodone prescriptions from Rand not for a legitimate medical purpose and ultimately distributed at least 500 oxycodone pills in 30 milligram dosages to others.  

In addition, West arranged the distribution of oxycodone via text messages to co-defendants, each of whom were at one time or another employees of the vehicle dealership.  West referred several of the co-defendants to Rand to obtain prescriptions for painkillers, some of which were prescribed and obtained for neither a legitimate medical purpose nor in the usual course of medical practice.  At the time of West’s arrest, he possessed a Sig Sauer pistol in furtherance of the conspiracy to distribute and possess with intent to distribute controlled substances.

Co-defendants Rand, 53, Omar Ahsan Ahmad, 31, Joshua Ross Green, 34, Clint Mitchell Bloodworth, 40, Kathleen Griffin, 43, Alan Russel Martinez, 59, and Braden Kyle Riley, 40, all of Reno, and Ryan Daniel Smith, 40, of Carson City, were each charged in the same conspiracy.  Rand is also charged with one count of distribution of oxycodone resulting in death and one count of distribution of fentanyl.  Jury trial is set for April 25, 2017, before U.S. District Judge Miranda M. Du.

According to the Centers for Disease Control and (CDC), almost two million Americans abused or were dependent on prescription opioids in 2014.  Every day, more than 1,000 people are treated in emergency departments for misusing prescription opioids.  Overdoses involving opioids killed more than 33,000 people in 2015, more than any year on record, and over one-half of those deaths were from prescription opioids.  For information on opioid overdose and how you can manage pain without prescription drugs, go to http://www.cdc.gov/drugoverdose/opioids/index.html.
The case is being investigated by the Northern Nevada Unified Drug and Gang Enforcement Task Force, which includes the DEA, FBI, IRS Criminal Investigation, ICE-HSI, ATF, Reno Police Department, Washoe County Sheriff’s Office, Carson City Sheriff’s Office, Susanville, California Police Department, Nevada Department of Corrections, Nevada Gaming Control, Nevada Department of Public Safety,  Lyon County Sheriff’s Office, and the State of Nevada Division of Welfare, Office of Investigations and Recovery.

The case is being by prosecuted by Assistant U.S. Attorneys James Keller, Sue Fahami, and Shannon Bryant.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Brian M. Clark Special Agent in Charge - Los Angeles
@dealosangeles
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster